Literature DB >> 31345146

Effects of Folic Acid and Vitamin B12, Alone and in Combination on Cognitive Function and Inflammatory Factors in the Elderly with Mild Cognitive Impairment: A Single-blind Experimental Design.

Fei Ma1,2, Xuan Zhou2,3, Qing Li2,3, Jiangang Zhao4, Aili Song4, Peilin An2,3, Yue Du2,5, Weili Xu1,2,6, Guowei Huang2,3.   

Abstract

BACKGROUND: Folate and vitamin B12 are well-known as essential nutrients that play key roles in the normal functions of the brain. Inflammatory processes play at least some role in the pathology of AD. Effective nutritional intervention approaches for improving cognitive deficits that reduce the peripheral inflammatory cytokine levels have garnered special attention.
OBJECTIVE: The present study aimed to determine whether supplementation with folic acid and vitamin B12, alone and in combination improves cognitive performance via reducing levels of peripheral inflammatory cytokines.
METHODS: 240 participants with MCI were randomly assigned in equal proportion to four treatment groups: folic acid alone, vitamin B12 alone, folic acid plus vitamin B12 or control without treatment daily for 6 months. Cognition was measured with WAIS-RC. The levels of inflammatory cytokines were measured using ELISA. Changes in cognitive function or blood biomarkers were analyzed by repeatedmeasure analysis of variance or mixed-effects models. This trial has been registered with trial number ChiCTR-ROC-16008305.
RESULTS: Compared with control group, the folic acid plus vitamin B12 group had significantly greater improvements in serum folate, homocysteine, vitamin B12 and IL-6, TNF-α, MCP-1. The folic acid plus vitamin B12 supplementation significantly changed the Full Scale IQ (effect size d = 0.169; P = 0.024), verbal IQ (effect size d = 0.146; P = 0.033), Information (d = 0.172; P = 0.019) and Digit Span (d = 0.187; P = 0.009) scores. Post hoc Turkey tests found that folic acid and vitamin B12 supplementation was significantly more effective than folic acid alone for all endpoints.
CONCLUSIONS: The combination of oral folic acid plus vitamin B12 in MCI elderly for six months can significantly improve cognitive performance and reduce the levels of inflammatory cytokines in human peripheral blood. The combination of folic acid and vitamin B12 was significantly superior to either folic acid or vitamin B12 alone. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Alzheimer's disease; Mild cognitive impairment; folic acid; peripheral inflammatory cytokines; single-blind experimentalzzm321990design; vitamin B12.

Year:  2019        PMID: 31345146     DOI: 10.2174/1567205016666190725144629

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  11 in total

1.  Reversal of Lipid Metabolism Dysregulation by Selenium and Folic Acid Co-Supplementation to Mitigate Pathology in Alzheimer's Disease.

Authors:  Zhong-Hao Zhang; Xian-Chun Cao; Jia-Ying Peng; Shao-Ling Huang; Chen Chen; Shi-Zheng Jia; Jia-Zuan Ni; Guo-Li Song
Journal:  Antioxidants (Basel)       Date:  2022-04-24

2.  Distinct effects of interleukin-6 and interferon-γ on differentiating human cortical neurons.

Authors:  Annie Kathuria; Kara Lopez-Lengowski; Joshua L Roffman; Rakesh Karmacharya
Journal:  Brain Behav Immun       Date:  2022-04-13       Impact factor: 19.227

Review 3.  The Role of Nutrition on Meta-inflammation: Insights and Potential Targets in Communicable and Chronic Disease Management.

Authors:  Omar Ramos-Lopez; Diego Martinez-Urbistondo; Juan A Vargas-Nuñez; J Alfredo Martinez
Journal:  Curr Obes Rep       Date:  2022-10-18

4.  The preventive efficacy of vitamin B supplements on the cognitive decline of elderly adults: a systematic review and meta-analysis.

Authors:  Shufeng Li; Yuchen Guo; Jie Men; Hanlin Fu; Ting Xu
Journal:  BMC Geriatr       Date:  2021-06-16       Impact factor: 3.921

Review 5.  Can We Treat Neuroinflammation in Alzheimer's Disease?

Authors:  Sandra Sánchez-Sarasúa; Iván Fernández-Pérez; Verónica Espinosa-Fernández; Ana María Sánchez-Pérez; Juan Carlos Ledesma
Journal:  Int J Mol Sci       Date:  2020-11-19       Impact factor: 5.923

6.  The Association Between Folate and Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Authors:  Xiaohong Zhang; Guangyi Bao; Debiao Liu; Yu Yang; Xuezhi Li; Gaomei Cai; Yan Liu; Yili Wu
Journal:  Front Neurosci       Date:  2021-04-14       Impact factor: 4.677

7.  Effects of Nutrition on Cognitive Function in Adults with or without Cognitive Impairment: A Systematic Review of Randomized Controlled Clinical Trials.

Authors:  Laia Gutierrez; Alexandre Folch; Melina Rojas; José Luis Cantero; Mercedes Atienza; Jaume Folch; Antoni Camins; Agustín Ruiz; Christopher Papandreou; Mònica Bulló
Journal:  Nutrients       Date:  2021-10-22       Impact factor: 5.717

Review 8.  Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors.

Authors:  Ruth Peters; John Breitner; Sarah James; Gregory A Jicha; Pierre-Francois Meyer; Marcus Richards; A David Smith; Hussein N Yassine; Erin Abner; Atticus H Hainsworth; Patrick G Kehoe; Nigel Beckett; Christopher Weber; Craig Anderson; Kaarin J Anstey; Hiroko H Dodge
Journal:  Alzheimers Dement (N Y)       Date:  2021-12-08

Review 9.  Mechanistic Link between Vitamin B12 and Alzheimer's Disease.

Authors:  Anna Andrea Lauer; Heike Sabine Grimm; Birgit Apel; Nataliya Golobrodska; Lara Kruse; Elina Ratanski; Noemi Schulten; Laura Schwarze; Thomas Slawik; Saskia Sperlich; Antonia Vohla; Marcus Otto Walter Grimm
Journal:  Biomolecules       Date:  2022-01-14

10.  B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment.

Authors:  Hieronim Jakubowski; Anetta Zioła-Frankowska; Marcin Frankowski; Joanna Perła-Kaján; Helga Refsum; Celeste A de Jager; A David Smith
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.